These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 2551147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC, Myones BL, Frazier B, Holers VM.
    J Biol Chem; 1990 Jul 25; 265(21):12293-9. PubMed ID: 1695627
    [Abstract] [Full Text] [Related]

  • 4. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT, Ahearn JM.
    Curr Top Microbiol Immunol; 1990 Jul 25; 153():83-98. PubMed ID: 2153507
    [No Abstract] [Full Text] [Related]

  • 5. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT.
    J Exp Med; 1991 May 01; 173(5):1083-9. PubMed ID: 1708808
    [Abstract] [Full Text] [Related]

  • 6. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD, Fearon DT.
    Immunodefic Rev; 1990 May 01; 2(1):17-41. PubMed ID: 2164822
    [Abstract] [Full Text] [Related]

  • 7. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT.
    J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).
    Fearon DT, Klickstein LB, Wong WW, Wilson JG, Moore FD, Weis JJ, Weis JH, Jack RM, Carter RH, Ahearn JA.
    Prog Clin Biol Res; 1989 Mar 01; 297():211-20. PubMed ID: 2531419
    [No Abstract] [Full Text] [Related]

  • 9. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr 01; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 10. [Complement receptors].
    Kinoshita T.
    Seikagaku; 1989 Aug 01; 61(8):704-9. PubMed ID: 2532238
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor.
    Nemerow GR, Moore MD, Cooper NR.
    Adv Cancer Res; 1990 Aug 01; 54():273-300. PubMed ID: 2136962
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
    Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.
    J Virol; 1991 Jul 01; 65(7):3559-65. PubMed ID: 1645784
    [Abstract] [Full Text] [Related]

  • 14. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.
    Eur J Immunol; 1990 Feb 01; 20(2):409-16. PubMed ID: 1690137
    [Abstract] [Full Text] [Related]

  • 15. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC, Fischer E, Bismuth G, Kazatchkine MD.
    J Immunol; 1992 Aug 01; 149(3):768-74. PubMed ID: 1386093
    [Abstract] [Full Text] [Related]

  • 16. Structure and signalling functions of C3 receptors on human B cells.
    Frade R.
    Semin Immunol; 1990 Mar 01; 2(2):159-64. PubMed ID: 2151800
    [Abstract] [Full Text] [Related]

  • 17. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.
    J Virol; 1987 May 01; 61(5):1416-20. PubMed ID: 3033269
    [Abstract] [Full Text] [Related]

  • 18. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR, Hsu PH, Bartow TJ, Ahearn JM, Matsumoto AK, Klickstein LB, Fearon DT.
    J Exp Med; 1991 Dec 01; 174(6):1451-60. PubMed ID: 1836011
    [Abstract] [Full Text] [Related]

  • 19. Cell surface proteins reacting with activated complement components.
    Becherer JD, Alsenz J, Servis C, Myones BL, Lambris JD.
    Complement Inflamm; 1989 Dec 01; 6(3):142-65. PubMed ID: 2526003
    [Abstract] [Full Text] [Related]

  • 20. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR, Ahearn JM, Fearon DT.
    J Immunol; 1991 Jul 15; 147(2):590-4. PubMed ID: 1830068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.